Poor Adherence: The Conceivable Cause of Cardiovascular Diseases in People on Antiretroviral Therapy

Mteto Qhayiya  Fihla

doi:10.25159/2520-5293/13551

Authors

Mteto Qhayiya Fihla Walter Sisulu University https://orcid.org/0000-0001-5789-4349

DOI:

https://doi.org/10.25159/2520-5293/13551

Keywords:

adherence, antiretrovirals, antiretroviral therapy, cardiovascular diseases, human immunodeficiency virus (HIV)

Abstract

Apart from the deterrence of human immunodeficiency virus (HIV) progression, antiretroviral therapy (ART) has been associated with the development of cardiovascular diseases (CVD), as with HIV itself. With both HIV and ART being linked to CVDs in similar mechanisms, there is not yet an established relationship between ART and CVDs using adherence in people living with HIV (PLWH). The use of adherence may help shed light on understanding whether the CVDs are a result of ART or HIV due to poor adherence. Henceforth, the aim of this paper was to explore the possible relationship between ART adherence and CVDs. Based on evidence from the literature, there is convincing evidence to suggest that CVDs in people on ART are from HIV itself as a result of uncontrolled viremia due to poor adherence to ART.

Metrics

Metrics Loading ...

References

Azia, I. N., F. C. Mukumbang, and B. van Wyk. 2016. “Barriers to Adherence to Antiretroviral Treatment in a Regional Hospital in Vredenburg, Western Cape, South Africa.” Southern African Journal of HIV Medicine 17 (1): 476. https://doi.org/10.4102/sajhivmed.v17i1.476.

Azzoni, L., D. Metzger, and L. Montaner. 2020. “Effect of Opioid Use on Immune Activation and HIV Persistence on ART.” Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology: 15. https://doi.org/10.1007/s11481-020-09959-y.

Bishop, J. D., S. DeShields, T. Cunningham, and S. B. Troy. 2016. “CD4 Count Recovery after Initiation of Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus.” The American Journal of the Medical Sciences 352 (3): 239–244. https://doi.org/10.1016/j.amjms.2016.05.032.

Byrd, K. K., J. G. Hou, R. Hazen, H. Kirkham, S. Suzuki, and P. G. Clay. 2019. “Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-world Data.” Journal of Acquired Immune Deficiency Syndromes 82 (3): 245–51. https://doi.org/10.1097/QAI.0000000000002142.

Castillo-Mancilla, J. R., T. T. Brown, F. J. Palella, B. J. C. Macatangay, E. C. Breen, L. P. Jacobson, and N. I. Wada. 2020. “Partial Normalisation of Biomarkers of Inflammation and Immune Activation among Virally Suppressed Men with HIV Infection and High ART Adherence.” Open Forum Infect Dis.7 (4): ofaa099. https://doi.org/10.1093/ofid/ofaa099.

Collins, D. R., G. D. Gaiha, and B. D. Walker. 2020. “CD8+ T Cells in HIV Control, Cure and Prevention.” Nat Rev Immunol 20: 471–482. https://doi.org/10.1038/s41577-020-0274-9.

Crakes, K. R., and G. Jiang. 2019. “Gut Microbiome Alterations during HIV/SIV Infection: Implications for HIV Cure.” Frontiers in Microbiology, 10. https://doi.org/10.3389/fmicb.2019.01104.

Da Cunha, J., L. M. Maselli, A. C. Stern, C. Spada, and S. P. Bydlowski. 2015. “Impact of Antiretroviral Therapy on Lipid Metabolism of Human Immunodeficiency Virus-infected Patients: Old and New Drugs.” World Journal of Virology 4 (2): 56–77. https://doi.org/10.5501/wjv.v4.i2.56.

Dillon, S. M., D. N. Frank, and C. C. Wilson. 2016. “The Gut Microbiome and HIV-1 Pathogenesis: A Two-way Street.” AIDS (London, England) 30 (18): 2737–2751. https://doi.org/10.1097/QAD.0000000000001289.

Dinh, Q. N., G. R. Drummond, C. G. Sobey, and S. Chrissobolis. 2014. “Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension.” Biomed Res Int. 2014: 406960. https://doi.org/10.1155/2014/406960.

Dirajlal-Fargo, S., and N. Funderburg. 2022. “HIV and Cardiovascular Disease: The Role of Inflammation.” Current Opinion in HIV and AIDS 17 (5): 286–292. https://doi.org/10.1097/COH.0000000000000755.

Eyawo, O., G. Brockman, C. H. Goldsmith, M. W. Hull, S. A. Lear, M. Bennett, S. Guillemi, C. Franco-Villalobos, A. Adam, E. J. Mills, J. S. G. Montaner, and R. S. Hogg. 2019. “Risk of Myocardial Infarction among People Living with HIV: An Updated Systematic Review and Meta-analysis.” BMJ Open 9 (9): e025874. https://doi.org/10.1136/bmjopen-2018-025874.

Feinstein, M. J., P. Y. Hsue, L. A. Benjamin, G. S. Bloomfield, J. S. Currier, M. S. Freiberg, S. K. Grinspoon, J. Levin, C. T. Longenecker, and W. S. Post. 2019. “Characteristics, Prevention, and Management of Cardiovascular Disease in People Living with HIV: A Scientific Statement from the American Heart Association.” Circulation 140 (2): e98-e124. https://doi.org/10.1161/CIR.0000000000000695.

Funderburg, N. T., and N. N. Mehta. 2016. “Lipid Abnormalities and Inflammation in HIV Infection.” Curr HIV/AIDS Rep. 13 (4): 218–25. https://doi.org/10.1007/s11904-016-0321-0.

Glavan, T. W., C. A. Gaulke, C. Santos Rocha, S. Sankaran-Walters, L. A. Hirao, and M. Raffatellu. 2016. “Gut Immune Dysfunction through Impaired Innate Pattern Recognition Receptor Expression and Gut Microbiota Dysbiosis in Chronic SIV Infection.” Mucosal Immunology 9: 677–688. https://doi.org/10.1038/mi.2015.92.

Ling, Z., C. Jin, T. Xie, Y. Cheng, L. Li, and N. Wu. 2016. “Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in a Chinese Population.” Sci. Rep. 6: 30673. https://doi.org/10.1038/srep30673.

Mak, G., J. J. Zaunders, M. Bailey, N. Seddiki, G. Rogers, L. Leong, T. G. Phan, A. D. Kelleher, K. K. Koelsch, M. A. Boyd, and M. Danta. 2021. “Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients with Controlled HIV Infection.” Frontiers in Immunology 12: 688886. https://doi.org/10.3389/fimmu.2021.688886.

Moosa, A., T. N. Gengiah, L. Lewis, and K. Naidoo. 2019. “Long-term Adherence to Antiretroviral Therapy in a South African Adult Patient Cohort: A Retrospective Study.” BMC Infectious Diseases 19: 775. https://doi.org/10.1186/s12879-019-4410-8.

Moszak, M., M. Szulińska, and P. Bogdański. 2020. “You Are What You Eat: The Relationship between Diet, Microbiota, and Metabolic Disorders: A Review.” Nutrients 12 (4): 1096. https://doi.org/10.3390/nu12041096.

Nowak, P., M. Troseid, E. Avershina, B. Barqasho, U. Neogi, and K. Holm. 2015. “Gut Microbiota Diversity Predicts Immune Status in HIV-1 Infection.” AIDS 29: 2409–2418. https://doi.org/10.1097/QAD.0000000000000869.

Nyambuya, T. M., P. V. Dludla, V. Mxinwa, and B. B. Nkambule. 2020. “The Effect of Successful Antiretroviral Therapy on Immune Activation and Reconstitution in HIV Infected Adults: A Systematic Review and Meta-analysis.” AIDS Reviews 23 (3). https://doi.org/10.24875/AIDSRev.20000039.

Ruamtawee, W., M. Tipayamongkholgul, N. Aimyong, and W. Manosuthi. 2023. “Prevalence and Risk Factors of Cardiovascular Disease among People Living with HIV in the Asia-Pacific Region: A Systematic Review.” BMC Public Health (23): 4777. https://doi.org/10.1186/s12889-023-15321-7.

Sarnelli, G., L. Seguella, M. Pesce, J. Jie Lu, S. Gigli, E. Bruzzese, R. Lattanzi, A. D’Alessandro, R. Cuomo, L. Steardo, and G. Esposito. 2018. “HIV-1 Tat-induced Diarrhea Is Improved by the PPAR Alpha Agonist, Palmitoylethanolamide, by Suppressing the Activation of Enteric Glia.” J Neuroinflammation 15: 94. https://doi.org/10.1186/s12974-018-1126-4.

Saxena, R., and V. K. Sharma. 2016. “A Metagenomic Insight Into the Human Microbiome: Its Implications in Health and Disease.” Medical and Health Genomics, 107–119. https://doi.org/10.1016/B978-0-12-420196-5.00009-5.

Tseng, A., J. Seet, and E. J. Phillips. 2015. “The Evolution of Three Decades of Antiretroviral Therapy: Challenges, Triumphs and the Promise of the Future.” British Journal of Clinical Pharmacology 79 (2): 182–194. https://doi.org/10.1111/bcp.12403.

UNAIDS, Joint UN Programme, Country Factsheets South Africa. 2017. Accessed April 30, 2023. http://www.unaids.org/en/regionscountries/countries/southafrica.

Vidya Vijayan, K. K., K. P. Karthigeyan, S. P. Tripathi, and L. E. Hanna. 2017. “Pathophysiology of CD4+ T-cell Depletion in HIV-1 and HIV-2 Infections.” Frontiers in Immunology 8: 580. https://doi.org/10.3389/fimmu.2017.00580.

Villanueva-Millan, M. J., P. Perez-Matute, E. Recio-Fernandez, J. M. Lezana Rosales, and J. A. Oteo. 2017. “Differential Effects of Antiretrovirals on Microbial Translocation and Gut Microbiota Composition of HIV-infected Patients.” Journal of International AIDS Society 20: 21526. https://doi.org/10.7448/IAS.20.1.21526.

Yoon, M. Y., K. Y. Lee, and S. Sang. 2014. “Protective Role of Gut Commensal Microbes against Intestinal Infections.” Journal of Microbiology, 52. https://doi.org/10.1007/s12275-014-4655-2.